These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 35804298

  • 1. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
    Lin S, Hua W, Wang S, Zhang Y, Chen X, Liu H, Shao L, Chen J, Zhang W.
    BMC Microbiol; 2022 Jul 08; 22(1):175. PubMed ID: 35804298
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC, Wu MF, Chen HC, Huang WC.
    J Microbiol Immunol Infect; 2018 Oct 08; 51(5):636-643. PubMed ID: 28705770
    [Abstract] [Full Text] [Related]

  • 3. Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China.
    Li Y, Liu C, Ma A, He W, Qiu Q, Zhao Y, Li Y.
    J Glob Antimicrob Resist; 2022 Dec 08; 31():90-97. PubMed ID: 35660663
    [Abstract] [Full Text] [Related]

  • 4. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I, Maugein J, Lapeyre C, Barbeau P, Leng B, Pellegrin JL.
    J Antimicrob Chemother; 1996 Mar 08; 37(3):501-10. PubMed ID: 9182107
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
    Sirichoat A, Kaewprasert O, Hinwan Y, Faksri K.
    PLoS One; 2023 Mar 08; 18(11):e0294677. PubMed ID: 37992075
    [Abstract] [Full Text] [Related]

  • 6. Difference in drug susceptibility distribution and clinical characteristics between Mycobacterium avium and Mycobacterium intracellulare lung diseases in Shanghai, China.
    Wang W, Yang J, Wu X, Wan B, Wang H, Yu F, Guo Y.
    J Med Microbiol; 2021 May 08; 70(5):. PubMed ID: 33999797
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Lee MR, Chien JY, Huang YT, Liao CH, Shu CC, Yu CJ, Hsueh PR.
    Int J Antimicrob Agents; 2017 Jul 08; 50(1):35-40. PubMed ID: 28478210
    [Abstract] [Full Text] [Related]

  • 9. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr 08; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G, Wu L, Zheng Q, Jiang X.
    Ann Med; 2022 Dec 08; 54(1):2500-2510. PubMed ID: 36120867
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.
    Zhao X, Wang Y, Pang Y.
    Infect Genet Evol; 2014 Oct 08; 27():332-8. PubMed ID: 25131955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
    Fröberg G, Maurer FP, Chryssanthou E, Fernström L, Benmansour H, Boarbi S, Mengshoel AT, Keller PM, Viveiros M, Machado D, Fitzgibbon MM, Mok S, Werngren J, Cirillo DM, Alcaide F, Hyyryläinen HL, Aubry A, Andres S, Nadarajan D, Svensson E, Turnidge J, Giske CG, Kahlmeter G, Cambau E, van Ingen J, Schön T, EUCAST AMST and ESCMYC study groups.
    Clin Microbiol Infect; 2023 Jun 08; 29(6):758-764. PubMed ID: 36813087
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.
    Maurer FP, Pohle P, Kernbach M, Sievert D, Hillemann D, Rupp J, Hombach M, Kranzer K.
    Clin Microbiol Infect; 2019 Mar 08; 25(3):379.e1-379.e7. PubMed ID: 29906595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.